Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Neurointerv Surg ; 11(11): e10, 2019 Nov.
Article in English | MEDLINE | ID: mdl-30679205

ABSTRACT

Intracranial vascular pathologies often have overlapping clinical presentations. Dissected vessel occlusions and bifurcation aneurysms can appear similar on pretherapeutic imaging. The medical management of these two entities is drastically different. The patient is a 51-year-old man who presented with severe, sudden-onset headache. Initial presentation was consistent with a ruptured middle cerebral artery (MCA) aneurysm and surgical clipping was recommended. However, further review of radiographic findings could not definitively differentiate an aneurysmal origin of the symptoms as opposed to intracranial dissection followed by occlusion of the M2 branch of the MCA. MRI sampling perfection with application optimised contrasts using different flip angle evolution (SPACE) was performed and showed thin flow signalling distal to the dissected vessel stump confirming the diagnosis. Accurate diagnosis is a crucial step in directing treatment for intracranial vascular lesions. MRI SPACE is a simple tool in the diagnostic armamentarium to adequately direct treatment and avoid the potential for unnecessary interventions.


Subject(s)
Infarction, Middle Cerebral Artery/diagnostic imaging , Infarction, Middle Cerebral Artery/surgery , Intracranial Aneurysm/diagnostic imaging , Intracranial Aneurysm/surgery , Aneurysm, Ruptured/diagnostic imaging , Aneurysm, Ruptured/surgery , Humans , Male , Middle Aged , Middle Cerebral Artery/diagnostic imaging , Middle Cerebral Artery/surgery
2.
BMJ Case Rep ; 20182018 Sep 18.
Article in English | MEDLINE | ID: mdl-30232067

ABSTRACT

Intracranial vascular pathologies often have overlapping clinical presentations. Dissected vessel occlusions and bifurcation aneurysms can appear similar on pretherapeutic imaging. The medical management of these two entities is drastically different. The patient is a 51-year-old man who presented with severe, sudden-onset headache. Initial presentation was consistent with a ruptured middle cerebral artery (MCA) aneurysm and surgical clipping was recommended. However, further review of radiographic findings could not definitively differentiate an aneurysmal origin of the symptoms as opposed to intracranial dissection followed by occlusion of the M2 branch of the MCA. MRI sampling perfection with application optimised contrasts using different flip angle evolution (SPACE) was performed and showed thin flow signalling distal to the dissected vessel stump confirming the diagnosis. Accurate diagnosis is a crucial step in directing treatment for intracranial vascular lesions. MRI SPACE is a simple tool in the diagnostic armamentarium to adequately direct treatment and avoid the potential for unnecessary interventions.


Subject(s)
Infarction, Middle Cerebral Artery/diagnostic imaging , Intracranial Aneurysm/diagnostic imaging , Middle Cerebral Artery/diagnostic imaging , Subarachnoid Hemorrhage/diagnostic imaging , Cerebral Angiography/methods , Dissection , Embolization, Therapeutic/instrumentation , Humans , Infarction, Middle Cerebral Artery/therapy , Intracranial Aneurysm/complications , Magnetic Resonance Imaging/methods , Male , Middle Aged , Middle Cerebral Artery/pathology , Middle Cerebral Artery/surgery , Tomography, X-Ray Computed/methods , Treatment Outcome
3.
J Neurointerv Surg ; 10(9): 823-827, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29352059

ABSTRACT

BACKGROUND AND PURPOSE: Blood pressure variability has been found to contribute to worse outcomes after intravenous tissue plasminogen activator, but the association has not been established after intra-arterial therapies. METHODS: We retrospectively reviewed patients with an ischemic stroke treated with intra-arterial therapies from 2005 to 2015. Blood pressure variability was measured as standard deviation (SD), coefficient of variation (CV), and successive variation (SV). Ordinal logistic regression models were fitted to the outcome of the modified Rankin Scale (mRS) with univariable predictors of systolic blood pressure variability. Multivariable ordinal logistic regression models were fitted to the outcome of mRS with covariates that showed independent predictive ability (P<0.1). RESULTS: There were 182 patients of mean age 63.2 years and 51.7% were female. The median admission National Institutes of Health Stroke Scalescore was 16 and 47.3% were treated with intravenous tissue plasminogen activator. In a univariable ordinal logistic regression analysis, systolic SD, CV, and SV were all significantly associated with a 1-point increase in the follow-up mRS (OR 2.30-4.38, all P<0.002). After adjusting for potential confounders, systolic SV was the best predictor of a 1-point increase in mRS at follow-up (OR 2.63-3.23, all P<0.007). CONCLUSIONS: Increased blood pressure variability as measured by the SD, CV, and SV consistently predict worse neurologic outcomes as measured by follow-up mRS in patients with ischemic stroke treated with intra-arterial therapies. The SV is the strongest and most consistent predictor of worse outcomes at all time intervals.


Subject(s)
Blood Pressure/physiology , Hypertension/etiology , Stroke/therapy , Thrombectomy/trends , Tissue Plasminogen Activator/administration & dosage , Administration, Intravenous , Aged , Aged, 80 and over , Blood Pressure/drug effects , Female , Follow-Up Studies , Humans , Hypertension/diagnostic imaging , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Postoperative Complications/etiology , Retrospective Studies , Stroke/diagnostic imaging , Thrombectomy/adverse effects , Tissue Plasminogen Activator/adverse effects , Treatment Outcome
4.
J Stroke Cerebrovasc Dis ; 23(7): 1890-6, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24813258

ABSTRACT

Few data exist about health-related quality of life outcomes after intra-arterial therapy (IAT) for acute ischemic stroke (AIS). We assessed stroke-specific quality of life (SS-QOL) in survivors of stroke after IAT. Consecutive patients undergoing IAT for AIS from 2005 to 2010 were retrospectively identified via an institutional database. SS-QOL (using the SS-QOL score) and disability status (modified Rankin Scale [mRS]) were prospectively assessed via mailed questionnaire. We analyzed quality of life (QOL) scores by domain and summary score, with a summary score of 4 or more defined as a good outcome. Analysis of variance (ANOVA) was used to model the effect of final recanalization status, stroke severity, and mRS on total QOL score. ANOVA and Pearson correlations were used to test the association between stroke severity/mRS and QOL/time since stroke, respectively. Of 99 patients with AIS, 61 responded, yielding 11 interim deaths, 7 incomplete surveys, and 43 complete surveys for analysis. Among responding survivors, overall QOL score was 3.9 (standard deviation 0.7); 77% of these reported good QOL. Scores were higher in recanalized patients in 11 of 12 domains but was significant only for mood. Although mRS was associated with stroke severity, QOL was independent of both. Seventy-seven percent of survivors of AIS who received IAT reported good QOL. Furthermore, these data suggest that SS-QOL is an independent outcome from stroke severity and disability status.


Subject(s)
Brain Ischemia/drug therapy , Brain Ischemia/psychology , Fibrinolytic Agents/therapeutic use , Quality of Life , Stroke/drug therapy , Stroke/psychology , Thrombolytic Therapy/methods , Tissue Plasminogen Activator/therapeutic use , Aged , Female , Fibrinolytic Agents/administration & dosage , Health Surveys , Humans , Injections, Intra-Arterial , Male , Middle Aged , Recurrence , Retrospective Studies , Surveys and Questionnaires , Survivors , Tissue Plasminogen Activator/administration & dosage , Treatment Outcome
5.
Lancet Neurol ; 11(10): 860-7, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22954705

ABSTRACT

BACKGROUND: Whether endovascular stroke treatment improves clinical outcomes is unclear because of the paucity of data from randomised placebo-controlled trials. We aimed to establish whether MRI can be used to identify patients who are most likely to benefit from endovascular reperfusion. METHODS: In this prospective cohort study we consecutively enrolled patients scheduled to have endovascular treatment within 12 h of onset of stroke at eight centres in the USA and one in Austria. Aided by an automated image analysis computer program, investigators interpreted a baseline MRI scan taken before treatment to establish whether the patient had an MRI profile (target mismatch) that suggested salvageable tissue was present. Reperfusion was assessed on an early follow-up MRI scan (within 12 h of the revascularisation procedure) and defined as a more than 50% reduction in the volume of the lesion from baseline on perfusion-weighted MRI. The primary outcome was favourable clinical response, defined as an improvement of 8 or more on the National Institutes of Health Stroke Scale between baseline and day 30 or a score of 0-1 at day 30. The secondary clinical endpoint was good functional outcome, defined as a modified Rankin scale score of 2 or less at day 90. Analyses were adjusted for imbalances in baseline predictors of outcome. Investigators assessing outcomes were masked to baseline data. FINDINGS: 138 patients were enrolled. 110 patients had catheter angiography and of these 104 had an MRI profile and 99 could be assessed for reperfusion. 46 of 78 (59%) patients with target mismatch and 12 of 21 (57%) patients without target mismatch had reperfusion after endovascular treatment. The adjusted odds ratio (OR) for favourable clinical response associated with reperfusion was 8·8 (95% CI 2·7-29·0) in the target mismatch group and 0·2 (0·0-1·6) in the no target mismatch group (p=0·003 for difference between ORs). Reperfusion was associated with increased good functional outcome at 90 days (OR 4·0, 95% CI 1·3-12·2) in the target mismatch group, but not in the no target mismatch group (1·9, 0·2-18·7). INTERPRETATION: Target mismatch patients who had early reperfusion after endovascular stroke treatment had more favourable clinical outcomes. No association between reperfusion and favourable outcomes was present in patients without target mismatch. Our data suggest that a randomised controlled trial of endovascular treatment for patients with the target mismatch profile is warranted. FUNDING: National Institute for Neurological Disorders and Stroke.


Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Endovascular Procedures/methods , Magnetic Resonance Angiography/methods , Reperfusion/methods , Stroke/therapy , Aged , Diffusion Magnetic Resonance Imaging/instrumentation , Endovascular Procedures/instrumentation , Female , Humans , Magnetic Resonance Angiography/instrumentation , Male , Middle Aged , Prospective Studies , Severity of Illness Index , Stroke/diagnosis , Time Factors , Treatment Outcome
6.
Spine (Phila Pa 1976) ; 37(23): E1476-8, 2012 Nov 01.
Article in English | MEDLINE | ID: mdl-22858787

ABSTRACT

STUDY DESIGN: A case report. OBJECTIVE: We report a case of delayed anterior spinal artery syndrome after repair of aortic coarctation in which the symptoms did not appear until 6 months after surgery. SUMMARY OF BACKGROUND DATA: Residual dilatation of the anterior spinal artery after surgery can mimic a dilated intraspinal vein, which could lead to the erroneous diagnosis of spinal arteriovenous malformation as the cause for anterior spinal artery syndrome. METHODS: A 40-year-old man with a history of hypertension underwent surgical bypass of the left subclavian artery to descending thoracic aorta to treat coarctation of the thoracic aorta and had an uncomplicated postoperative course. Six months later, he developed numbness and weakness in his hands. Magnetic resonance image showed abnormal signal within the cervicothoracic spinal cord and prominent flow voids within the ventral spinal canal. Spinal digital subtraction angiography revealed slow flow in a dilated intraspinal vessel. Given the history of aortic coarctation repair, the possibility that this represented a residually dilated anterior spinal artery rather than an arteriovenous malformation was considered and confirmed on magnetic resonance imaging. RESULTS: In our patient, institution of an anticoagulation medication regime resulted in rapid improvement of neurological symptoms, underscoring the importance of the awareness of this phenomenon. CONCLUSION: Delayed anterior spinal artery syndrome after aortic coarctation repair because of anterior spinal artery thrombosis can manifest even 6 months postoperatively. Careful analysis of pre- and postoperative cross-sectional imaging should provide the correct diagnosis. Spinal digital subtraction angiography is probably unnecessary and must be interpreted with caution.


Subject(s)
Anterior Spinal Artery Syndrome/etiology , Aorta, Thoracic/surgery , Aortic Coarctation/surgery , Vascular Grafting/adverse effects , Adult , Angiography, Digital Subtraction , Anterior Spinal Artery Syndrome/diagnosis , Anterior Spinal Artery Syndrome/drug therapy , Anticoagulants/therapeutic use , Aorta, Thoracic/abnormalities , Humans , Magnetic Resonance Imaging , Male , Predictive Value of Tests , Subclavian Artery/surgery , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...